Randall Brand

University of Pittsburgh

Appearances

MULTI-CENTER BLINDED VALIDATION OF THE DIAGNOSTIC UTILITY OF CYST GLUCOSE AND AMPHIREGULIN TO DIFFERENTIATE MUCINOUS FROM NON-MUCINOUS PANCREATIC CYSTS.
Date
May 9, 2023
BACKGROUND AND AIMS: Currently, most patients with branch duct intraductal papillary mucinous neoplasms (BD-IPMN) are offered indefinite surveillance, resulting in health care costs with questionable benefits regarding cancer prevention…
Presenter
Jessica Mar
Speakers
Aatur Singhi
Randall Brand
University of Pittsburgh
Ying Huang
Walter Park
Stanford University
AGA Pancreatic Cancer: Risk Factors, Biology, Diagnosis and Clinical Therapeutics
Date
May 7, 2023
SOCIETY: AGA
Moderators
Eileen Carpenter
University of Michigan
Randall Brand
University of Pittsburgh
A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA
Date
May 21, 2024
BACKGROUND: As outlined by the Kyoto guidelines, targeted DNA-based NGS of pancreatic cyst fluid (PCF) is an important adjunct to the evaluation of pancreatic cyst patients…
Presenter
Elham Afghani
Speakers
Anne Marie O'Broin-Lennon
Kevin Mcgrath
Tarek Sawas
Mayo Clinic
Nisa Kubiliun
Randall Brand
University of Pittsburgh
Walter Park
Stanford University
Patrick Pfau
University of Wisconsin
John M. Dewitt
Indiana University Health Medical Center
Shaffer Mok
Michael Wallace
Mayo Clinic
Shyam Thakkar
Tiffany Chua
Yasser Bhat
Nikhil Thiruvengadam
Tamas Gonda
Wasseem Skef
Mustafa Arain
AdventHealth Orlando
Andres Gelrud
Anjuli Luthra
Joanna Law
Asif Khalid
Rohit Das
Kenneth Fasanella
Harkirat Singh
Stephanie Romutis
Adam Slivka
Abigail Wald
Marina Nikiforova
Aatur Singhi